Maze Therapeutics, Inc. (MAZE) Institutional Ownership Changes & 13F Activity
Maze Therapeutics, Inc. (MAZE). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include T. Rowe Price Investment Management, Inc., Braidwell Lp, Farallon Capital Management Llc, Adage Capital Partners Gp, L.L.C., and Logos Global Management Lp.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Manufacturers Life Insurance Company, The | Buy | +1,832 | +12.6% | 16,402 | $489.44K | Q2 2026 | Sep 09, 2026 |
| Citadel Advisors Llc | Buy | +76,962 | +9.9% | 852,676 | $25.44M | Q2 2026 | Sep 02, 2026 |
| California State Teachers Retirement System | Buy | +24,628 | +1716.2% | 26,063 | $777.72K | Q2 2026 | Aug 24, 2026 |
| T. Rowe Price Investment Management, Inc. | Buy | +2,603,682 | — | 2,603,682 | $77.69M | Q2 2026 | Aug 14, 2026 |
| Braidwell Lp | Buy | +1,140,040 | — | 1,140,040 | $34.02M | Q2 2026 | Aug 14, 2026 |
| Farallon Capital Management Llc | Buy | +1,107,814 | — | 1,107,814 | $33.06M | Q2 2026 | Aug 14, 2026 |
| Adage Capital Partners Gp, L.L.C. | Sell | -930,000 | -78.9% | 248,000 | $7.40M | Q2 2026 | Aug 14, 2026 |
| Logos Global Management Lp | Buy | +700,000 | +56.7% | 1,935,000 | $57.74M | Q2 2026 | Aug 14, 2026 |
| Frazier Life Sciences Management, L.P. | Buy | +465,641 | +10.2% | 5,032,915 | $150.18M | Q2 2026 | Aug 14, 2026 |
| Balyasny Asset Management L.P. | Sell | -440,961 | -95.6% | 20,190 | $602.47K | Q2 2026 | Aug 14, 2026 |
| Driehaus Capital Management Llc | Buy | +318,724 | +50.1% | 954,886 | $28.49M | Q2 2026 | Aug 14, 2026 |
| Adar1 Capital Management, Llc | Buy | +289,181 | +577.3% | 339,276 | $10.12M | Q2 2026 | Aug 14, 2026 |
| Hudson Bay Capital Management Lp | Buy | +261,850 | +3212.9% | 270,000 | $8.06M | Q2 2026 | Aug 14, 2026 |
| Deep Track Capital, Lp | Buy | +255,007 | +7.3% | 3,732,569 | $111.38M | Q2 2026 | Aug 14, 2026 |
| Ameriprise Financial Inc | Buy | +227,425 | — | 227,425 | $6.79M | Q2 2026 | Aug 14, 2026 |
| Rtw Investments, Lp | Buy | +212,000 | — | 212,000 | $6.33M | Q2 2026 | Aug 14, 2026 |
| Sphera Funds Management Ltd. | Buy | +190,221 | +83.7% | 417,564 | $12.46M | Q2 2026 | Aug 14, 2026 |
| Exoduspoint Capital Management, Lp | Buy | +183,264 | — | 183,264 | $5.47M | Q2 2026 | Aug 14, 2026 |
| Two Sigma Investments, Lp | Buy | +177,107 | +1117.7% | 192,952 | $5.76M | Q2 2026 | Aug 14, 2026 |
| Bank Of America Corp | Buy | +126,143 | +64.7% | 321,227 | $9.59M | Q2 2026 | Aug 14, 2026 |
| Boothbay Fund Management, Llc | Sell | -95,619 | -33.6% | 188,857 | $5.64M | Q2 2026 | Aug 14, 2026 |
| Summittx Capital, L.P. | Buy | +92,541 | +110.5% | 176,291 | $5.26M | Q2 2026 | Aug 14, 2026 |
| Woodline Partners Lp | Buy | +85,987 | +13.2% | 736,216 | $21.97M | Q2 2026 | Aug 14, 2026 |
| Casdin Capital, Llc | Buy | +85,000 | +11.2% | 843,857 | $25.18M | Q2 2026 | Aug 14, 2026 |
| Ensign Peak Advisors, Inc | Sell | -84,150 | -45.3% | 101,644 | $3.03M | Q2 2026 | Aug 14, 2026 |
| Trexquant Investment Lp | Buy | +81,668 | — | 81,668 | $2.44M | Q2 2026 | Aug 14, 2026 |
| Squadron Capital Management Llc | Buy | +77,500 | +30.1% | 335,000 | $10.00M | Q2 2026 | Aug 14, 2026 |
| Charles Schwab Investment Management Inc | Buy | +74,133 | +39.8% | 260,566 | $7.78M | Q2 2026 | Aug 14, 2026 |
| Jacobs Levy Equity Management, Inc | Buy | +65,468 | — | 65,468 | $1.95M | Q2 2026 | Aug 14, 2026 |
| Xtx Topco Ltd | Buy | +48,463 | +180.5% | 75,317 | $2.25M | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about MAZE activity
Which institutional owners are buying MAZE?
Institutional owners buying MAZE include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in MAZE activity?
"Buy" means an investor increased their reported position in MAZE compared to the prior reporting period. This reflects growing exposure to Maze Therapeutics, Inc. (MAZE) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in MAZE increasing?
Institutional interest in MAZE can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.